All Stories

  1. Dasiglucagon—A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical Trial

    Article • Diabetes Care, June 2021, American Diabetes Association

    Thomas Pieber

  2. Pharmacokinetics and Pharmacodynamics of Three Different Formulations of Insulin Aspart: A Randomized, Double-Blind, Crossover Study in Men With Type 1 Diabetes

    Article • Diabetes Care, December 2020, American Diabetes Association

    Thomas Pieber

  3. Feasibility and safety of using an automated decision support system for insulin therapy in the treatment of steroid-induced hyperglycemia in patients with acute graft-versus-host disease: A randomized trial

    Article • Journal of Diabetes Investigation, October 2018, Wiley

    Thomas Pieber

  4. Short-term effects of dapagliflozin on insulin sensitivity, postprandial glucose excursion and ketogenesis in type 1 diabetes mellitus: A randomized, placebo-controlled, double blind, cross-over pilot study

    Article • Diabetes Obesity and Metabolism, July 2018, Wiley

    Thomas Pieber

  5. Improved glycaemic control and treatment satisfaction with a simple wearable 3-day insulin delivery device among people with Type 2 diabetes

    Article • Diabetic Medicine, July 2018, Wiley

    Thomas Pieber

  6. The effect of basal-bolus therapy varies with baseline 1,5-anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis

    Article • Diabetic Medicine, June 2018, Wiley

    Thomas Pieber

  7. Hypoglycaemia incidence and recovery during home use of hybrid closed-loop insulin delivery in adults with type 1 diabetes

    Article • Diabetes Obesity and Metabolism, April 2018, Wiley

    Sara Hartnell, Thomas Pieber

  8. Visceral leishmaniasis in a patient with diabetes mellitus type 2 and discrete bicytopenia

    Article • Clinical Case Reports, November 2017, Wiley

    Thomas Pieber

  9. Bolusing frequency and amount impacts glucose control during hybrid closed-loop

    Article • Diabetic Medicine, August 2017, Wiley

    Sara Hartnell, Thomas Pieber

  10. Faster insulin action is associated with improved glycaemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetes

    Article • Diabetes Obesity and Metabolism, June 2017, Wiley

    Sara Hartnell, Thomas Pieber

  11. High salivary testosterone-to-androstenedione ratio and adverse metabolic phenotypes in women with polycystic ovary syndrome

    Article • Clinical Endocrinology, January 2017, Wiley

    Thomas Pieber

  12. Bioavailability of insulin detemir and human insulin at the level of peripheral interstitial fluid in humans, assessed by open-flow microperfusion

    Article • Diabetes Obesity and Metabolism, October 2015, Wiley

    Thomas Pieber, Selma I. Mautner

  13. Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4‐week, randomized, placebo‐controlled trial ( EASE ‐1)

    Article • Diabetes Obesity and Metabolism, June 2015, Wiley

    Thomas Pieber

  14. Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial

    Article • Diabetes Obesity and Metabolism, May 2015, Wiley

    Thomas Pieber